Neurofilament-light chains (NF-L), a biomarker of neuronal damage, is increased in patients with severe sarcopenia: results of the SarcoPhAge study

BACKGROUND: As clinical tests, such as gait speed, require nervous system integrity to be performed properly, sarcopenia shares features with neurological diseases. Neurofilament light chains (NF-L) are now used as a blood-biomarker of neuronal damage, and its expression might be altered in sarcopen...

Descripción completa

Detalles Bibliográficos
Autores principales: Ladang, Aurélie, Kovacs, Stéphanie, Lengelé, Laetitia, Locquet, Médéa, Beaudart, Charlotte, Reginster, Jean-Yves, Bruyère, Olivier, Cavalier, Etienne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10520189/
https://www.ncbi.nlm.nih.gov/pubmed/37581861
http://dx.doi.org/10.1007/s40520-023-02521-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10520189/
https://www.ncbi.nlm.nih.gov/pubmed/37581861
http://dx.doi.org/10.1007/s40520-023-02521-9

Ejemplares similares